Resapp Health Saham

Resapp Health Beban Bunga

Beban Bunga dari Resapp Health (RAP.AX) pada 20 Agu 2026.

Beban Bunga

0,00AUD

Terakhir Diperbarui:

Beban Bunga dari Resapp Health adalah 2026 0,00 AUD. Beban Bunga dari Resapp Health adalah 2025 0,00 AUD. Menurun % lebih rendah dibandingkan dengan tahun sebelumnya.
Access this data via the Eulerpool API

Resapp Health Analisis saham

Apa yang dilakukan Resapp Health? ResApp Health Ltd is an Australian company that focuses on the development of digital diagnostic and treatment solutions in the field of respiratory diseases. The company was founded in 2014 by Tony Keating and Philippa Lewis, both of whom have significant experience in the medical technology industry. The company aims to improve and simplify the diagnosis of respiratory diseases by developing a diagnosis based on cough and breath sounds. To achieve this, the company has developed an intelligent system based on machine learning and artificial intelligence that analyzes individual sound waves and provides an accurate diagnostic capability. ResApp Health's business model is based on the development of digital diagnostic and treatment solutions in the field of respiratory diseases, which are offered through various distribution channels. The company offers both mobile apps and clinical diagnostic systems. ResApp Health operates in various divisions at different levels. On the one hand, the company conducts research and development to continuously improve its products. On the other hand, it works closely with clinicians, scientists, and other industry experts to enable the best possible patient treatment. Products offered by ResApp Health include digital diagnostic systems in the field of respiratory diseases that function based on cough and breath sounds. The products are offered for use in both clinical practice and at home to enable fast and accurate diagnosis. Another important area in which ResApp Health operates is the treatment of respiratory diseases. The company offers digital therapy platforms tailored to the individual needs of patients, enabling improved therapy. ResApp Health has already achieved a number of important milestones. For example, in 2016, the company received CE marking for its digital diagnostic system, and in 2017, it completed a clinical study that demonstrated the system's high accuracy in diagnosing respiratory diseases. Overall, ResApp Health has great potential to play an important role in the field of diagnosis and treatment of respiratory diseases in the future. With a strong focus on research and development and close collaboration with industry experts, the company will continue to offer innovative solutions to improve patient health. Resapp Health adalah salah satu perusahaan paling populer di Eulerpool.

Pertanyaan yang Sering Diajukan tentang saham Resapp Health

Di Eulerpool Anda dapat menemukan perkembangan historis lengkap Beban Bunga Resapp Health sejak 2006 – dengan nilai tahunan, bagan, dan analisis detail.

Beban bunga mewakili biaya peminjaman. Beban bunga yang lebih tinggi dapat menunjukkan perusahaan yang sangat terleverage.

AUD Beban Bunga adalah faktor kunci bagi investor. Perubahan metrik ini dapat menunjukkan fundamental yang membaik atau memburuk, secara langsung memengaruhi harga saham. Di Eulerpool, Anda dapat melacak Resapp Health Beban Bunga secara historis dan real-time.

Access this data via the Eulerpool API

Laporan Laba Rugi — Resapp Health

Semua Metrik Kunci — Resapp Health